Skip to main content

MS blood samples had more virus and brain antibodies

By MS Buddy ·

Summarized from Proceedings of the National Academy of Sciences of the United States of America, Mar 2025 · PubMed · DOI. AI-generated summary. Not medical advice.

Observational study · 1,311 people with MS and people without MS from the general population

Research by Neda Sattarnezhad, Tobias Lanz and 12 colleagues at Stanford University School of Medicine in the United States.

Do people with MS have different Epstein-Barr virus and brain antibody patterns?

Key Takeaway

People with MS had higher levels of antibodies against an Epstein-Barr virus protein and several proteins in the nervous system than people without MS.

Two blood drops side by side, one containing more Y-shaped antibody symbols than the other.
Credibility
Interest
Share:1 min read

What They Found

Researchers compared blood antibody responses in people with MS and people without MS. Antibody levels against one Epstein-Barr virus protein and three nervous system proteins were higher in the MS group. Lab tests showed that some antibodies reacted to both the virus protein and one nervous system protein. People with MS who carried a gene version linked to MS also had higher levels of these antibodies. Several antibody responses together were linked to higher odds of having MS.

Who Should Care and Why

The study included people with MS and people without MS from the general population. It examined antibodies, which are proteins the immune system makes to recognize targets. The findings may help researchers understand the link between Epstein-Barr virus and MS. They also show that the antibody patterns differed between the two groups. The abstract does not say whether these patterns can diagnose MS.

Important Considerations

The study compared 650 people with MS and 661 people without MS; it did not test a treatment. You cannot tell from this study whether these antibodies cause MS. The abstract does not show whether an antibody test could reliably diagnose MS in an individual.

AI-generated summary — for informational purposes only, not medical advice

Read the original abstract

Published in Proceedings of the National Academy of Sciences of the United States of America by et al.. Reproduced from the PubMed record.

Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS), which is linked to Epstein-Barr virus (EBV) infection, preceding the disease. The molecular mechanisms underlying this connection are only partially understood. We previously described molecular mimicry between the EBV transcription factor EBV nuclear antigen 1 (EBNA1) and three human CNS proteins: anoctamin-2 (ANO2), alpha-B crystallin (CRYAB), and glial cellular adhesion molecule (GlialCAM). Here, we investigated antibody responses against EBNA1 and GlialCAM in a large cohort of 650 MS patients and 661 matched population controls and compared them to responses against CRYAB and ANO2. We confirmed that elevated IgG responses against EBNA1 and all three CNS-mimic antigens associate with increased MS risk. Blocking experiments confirmed the presence of cross-reactive antibodies and molecular mimicry between EBNA1 and GlialCAM, and accompanying antibody responses against adjacent peptide regions of GlialCAM suggest epitope spreading. Antibody responses against EBNA1, GlialCAM, CRYAB, and ANO2 are elevated in MS patients carrying the main risk allele HLA-DRB1*15:01, and combinations of HLA-DRB1*15:01 with anti-EBNA1 and anti-GlialCAM antibodies increase MS risk significantly and in an additive fashion. In addition, antibody reactivities against more than one EBNA1 peptide and more than one CNS-mimic increase the MS risk significantly but modestly. Overall, we show that molecular mimicry between EBNA1 and GlialCAM is likely an important molecular mechanism contributing to MS pathology.

Categories

Early Research

Explore more research

The app

Check out the MS Buddy app

It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play

Related MS research

Muted blue and clay ribbons curve across an off-white background, wrapped in soft layers of varying thickness.
Planned MS study will test scans to track worsening

11/16/2026

A planned study will use detailed brain scans and blood tests to explore why relapsing-remitting MS

Read More
Two views of spinal cord nerve endings, with fewer chemical particles around the endings on the right.
Lab drug cut chemical release in MS-like mouse tissue

11/15/2026

In tissue from mice with an MS-like disease, a lab drug reduced excess chemical release from nerve e

Read More
A winding path links a DNA strand and a partly broken ring in a simple two-color print.
Review explores how immune genes may shape MS damage

11/13/2026

A review compares MS with harmful drug reactions and proposes ways to test how immune genes, lasting

Read More
Two differently colored molecular shapes near immune cells and a myelinated nerve fiber on a pale background.
Review links vitamin D and vitamin A immune signals to MS

11/13/2026

This review examines how vitamin D and vitamin A signals shape immune activity in MS and other disea

Read More
A folded paper shape beside two winding paths with slightly smoother stretches, in muted colors.
In MS-like mice, treatment helped movement and thinking

11/12/2026

In mice with an MS-like disease, a lab-made protein improved movement and thinking. Researchers also

Read More
A virus-shaped circle and a wrapped nerve fiber sit apart, connected by an incomplete dotted path.
Review proposes how Epstein-Barr virus may drive MS

11/12/2026

A review proposes how the Epstein-Barr virus might contribute to MS. The model brings earlier ideas

Read More

Not all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.